(19)

(11)

EP 4 816 336 A1

(12)

(43) Date of publication: 07.10.2026 Bulletin 2026/41 (21) Application number: 24895278.0 (22) Date of filing: 29.11.2024

(51) International Patent Classification (IPC):  C05B 7/00(2006.01) A01P 21/00(2006.01) C05F 11/08(2006.01) C12N 1/14(2026.01) A01N 63/30(2020.01) C05B 1/00(2006.01) C05G 1/00(2006.01) (52) Cooperative Patent Classification (CPC): A01N 63/30; A01P 21/00; C05B 7/00; C05F 11/08; C12N 1/14; C05G 3/90; C12R 2001/645; A01N 59/26   C-Sets: A01N 63/30, A01N 59/26, A01N 25/14, A01N 25/30, A01N 25/00; A01N 59/26, A01N 25/14, A01N 25/30, A01N 25/00; (86) International application number: PCT/CA2024/051604 (87) International publication number: WO 2025/111718 (05.06.2025 Gazette 2025/23)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 29.11.2023 US 202363603754 P (71) Applicant: BioSam Montréal, Québec H4B 1R6 (CA)	(72) Inventor: TAGHINASAB, Meysam Montréal, Québec H4B 1R6 (CA) (74) Representative: BCF Global  37 avenue de Friedland 75008 Paris 75008 Paris (FR)